Authors
Latest:
10 Ways to Respond to Patients in Emotional or Behavioral DistressWhen a patient is upset, agitated, or potentially violent, being empathetic and respectful are keys to defusing a potentially dangerous situation, says the Crisis Prevention Institute.
Latest:
Semaglutide Explored for Treatment of Alcohol, Nicotine Use DisordersFindings from 2 early stage studies reported at a recent clinical meeting support the safety and tolerability of the GLP-1RA in persons with substance use disorders.
Latest:
Preventive Care Skipped First by Millions for Financial ReasonsThe most common types of skipped care were preventive visits followed by Rx refills, mental health care, and diagnostic tests, a new survey found.
Latest:
How to Keep Patients Engaged with Primary CareThe pandemic has altered how patients access and use health care. Now is the time for primary care clinicians to rebuild important connections with them.
Latest:
New Doctors Could be Telehealth NativesConsider all the first year medical students introduced to patient care in 2020 via computer screens and monitors. A young telehealth native tells her story.
Latest:
ACIP Recommendations for RSV Vaccines in Older Adults: Update August 2024The Advisory Committee on Immunization Practices' revisions prioritize vulnerable older adults and those at higher risk of severe infection.
Latest:
Unmet Needs in Diabetes ManagementDr Diana Isaacs provides insight on current challenges in the clinical treatment of patients with diabetes and shares clinical pearls for the use of CGMs in disease management.
Latest:
Expert Insights: Patient Case Studies & Key Takeaways on T2D Management in Older PatientsMedha Munshi, MD, and James Bailey, III, MD, FACE, ECNU, discuss older adult patient cases and review their respective treatment approaches, sharing final takeaways to provide practical insights for managing diabetes in this patient population.
Latest:
The GLP-1RA Pipeline is Full - Here's What to ExpectThere are lots of products in development for weight loss and to treat other metabolic diseases which means more options for more people.
Latest:
For the Statin-Intolerant or Statin-Unwilling Patient, Part 2: Other Pharmaceutical OptionsFor the 1 in 3 individuals with hyperlipidemia who can't or won't take a statin, preventive cardiologist Elizabeth Klodas, MD, details 3 alternative drug classes.
Latest:
Take-Home Thoughts for Managing DiabetesEden Miller, DO, shares key takeaways on how personalized treatment helps in the management of diabetes.
Latest:
Practice Pearls for Discussing COVID-19 Vaccines with PatientsDrs Tina Q. Tan and Rodney Rohde share final thoughts on addressing patient and parent concerns with COVID-19 vaccines.
Latest:
Lilly Makes Tirzepatide Single-Dose Vials Available as Self-Pay Option at 50% DiscountVials of tirzepatide 2.5 mg and 5 mg will be available with a prescription for the labeled drug through LillyDirect after completing a multistep verification process, the company said.
Latest:
Roflumilast Associated with Increase in 5-Year Mortality Risk in Patients with COPDIn a large study of patients with COPD, a small increase in 5-year all-cause mortality risk was observed among those using roflumilast.
Latest:
Telemedicine vs In-person Care: In Addiction Medicine, Options are KeyCOVID-19 has dealt in-person addiction treatment a blow, but the chief medical officer of Groups Recover Together tells a telemedicine success story with a hybrid ending.
Latest:
Texting Patients? Don't Make these HIPAA MistakesTrain your staff well, says this expert in business texting solutions, and make sure to develop and use appropriate checks and balances.
Latest:
Patient Case 2: Tailoring Treatment for Complex Needs, Incorporating Cardiovascular, Weight, and Renal ConsiderationsThe expert panel concludes by analyzing a patient case and offering final insights on customizing treatment for complex geriatric diabetes patients, taking into account cardiovascular health, weight management, and renal function considerations.
Latest:
Vaccination Strategies Practice Pearls And Key Take AwaysDrs John Russell, Jacinda Abdul-Mutakabbir, Charles Vega, Wendy Wright, And Neil Skolnik provide their practice pearls and key thoughts on how to vaccinate their patient populations in the upcoming influenza season.
Latest:
For Unknown Causes of Kidney Disease, Genetic Testing Holds PromiseA recent American Kidney Fund survey of 300 primary care and specialty clinicians found ~15% of their patients had kidney disease of unknown origin.
Latest:
Efsitora Alfa, Eli Lilly’s Once Weekly Insulin, Has Positive Topline Results in Two TrialsAcross two clinical trials in the QWINT program, once-wekly efsitora showed comparable A1C reduction to frequently used daily insulins.
Latest:
Take-home Messages for Acute Pain ManagementBenjamin W. Friedman, MD, MS; Francesca Beaudoin, MD, MS, PhD; Paul Arnstein, RN, PhD, FAAN; and Jeff Gudin, MD, provide take-home messages to providers treating patients with acute pain.
Latest:
Cannabis: An "Ins and Outs" Primer for Primary CareA concise update on legal status, FDA approvals, patient safety, and public perception.
Latest:
Distinct Patterns of BP in Early Gestation Predict Hypertensive Disorders: StudyInvestigators identified 6 blood pressure patterns that, when combined with other risk factors, accurately stratified risk of hypertensive disorders of pregnancy.
Latest:
Final Pearls and Takeaways for Testing and Managing CKDExperts wrap up their discussion of emerging chronic kidney disease tests and treatments with key takeaways for providers and patients.
Latest:
FDA Ruling on National Breast Density Notification for Mammography Reports FinalizedBeginning on Sept 24, 2024, all women must be notified of their breast density status in mammography reports and encouraged to pursue supplemental screening.
Latest:
Two Biosimilars to Denosumab Win FDA Approval as Amgen and Sandoz Go to CourtBiosimilars Wyost and Jubobonti were approved as interchangeable for Xgeva and Prolia but launch will depend on the outcome of litigation between reference product manufacturers.
Latest:
First-Ever MDMA-Assisted Therapy for PTSD is Granted FDA Priority ReviewIf the FDA approves the treatment, it will be the first-ever MDMA-assisted therapy and psychedelic-assisted therapy. The PDUFA date is set for August 11, 2024.
Latest:
The Importance of Connecting Patients with ADPKD with Each OtherPeer mentor programs can provide support for patients, especially when it comes to family planning and parenthood.
Latest:
Michael A. Weber, MD, on aprocitentan approval: A new approach to managing hypertensionMichael A. Weber, MD, an investigator in the PRECISION study, discusses the newly FDA approved drug aprocitentan (Tryvio), and its promise for helping patients with treatment-resistant hypertension.
